Establishing New Partnerships to Advance Radiation Science and Medicine
Together with the Radiation Research Society, the AACR will present a workshop titled Targeting Cancer Metabolism to Improve Radiotherapy...
Together with the Radiation Research Society, the AACR will present a workshop titled Targeting Cancer Metabolism to Improve Radiotherapy...
Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still,...
A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
Last week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic acalabrutinib (Calquence) for treating adults...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Paul Northcott, PhD, inaugural recipient of the AACR NextGen Grant for Transformative Cancer Research, has dedicated his research career...